Skip to content
(RS)-troglitazone

Structure via PubChem · Public domain (PubChem)

EntityQ7844989· pop 13· linked from 366 articles

(RS)-troglitazone

Sign in to save

Also known as 5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione

Troglitazone is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for people with diabetes mellitus type 2.

Chemical data

Formula
C24H27NO5S
Molecular weight
441.5 g/mol
IUPAC name
5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
SMILES
CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
InChIKey
GXPHKUHSUJUWKP-UHFFFAOYSA-N
XLogP
5.1
Polar surface area
110 Ų
H-bond donors
2
H-bond acceptors
6
Formal charge
0

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule
First approval
1997
Admin. routes
oral
Indications
diabetes mellitus, sarcoma

via ChEMBL · EBI

Wikidata facts

Subclass of
glitazone
Mass
441.160994
Has use
medication
Show 6 more facts
chemical formula
C₂₄H₂₇NO₅S
canonical SMILES
CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O
Commons category
Troglitazone
defined daily dose
0.4
has effect
liver failure
Sources (6)

via Wikidata · CC0

~8 min read

Encyclopedic overview

6 sections
Contents
  • Mechanism of action
  • History
  • Mechanisms of hepatotoxicity
  • Lawsuits
  • References
  • External links

Troglitazone is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for people with diabetes mellitus type 2.

It was patented in 1983 and approved for medical use in 1997. It was subsequently withdrawn.

Excerpted from Wikipedia’s “(RS)-troglitazone” article, available under the CC BY-SA 4.0 licence.

Gallery (3)